Last edition
News about "Atrium Therapeutics"
Avidity Biosciences Sets Record Date for Atrium Therapeutics Spin Off Ahead of Novartis Merger
Avidity Biosciences announces February 12, 2026 as the record date for distributing Atrium Therapeutics shares to stockholders as part of its planned Novartis acquisition and cardiology spin-off.
Atrium Therapeutics | 03/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members